These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6203226)

  • 1. [Approaches to the design of antiviral vaccines (a theoretical review)].
    Dzagurov SG; Gnuni GM; Khvoles AG
    Vopr Virusol; 1984; 29(2):137-40. PubMed ID: 6203226
    [No Abstract]   [Full Text] [Related]  

  • 2. [Viruses and gene engineering].
    Tikhonenko TI
    Vestn Akad Med Nauk SSSR; 1983; (12):67-75. PubMed ID: 6198816
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
    Brown F
    Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

  • 5. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New technology of vaccine production--international prospect of the development. Method and theory of production of vaccines by genetic engineering. a. Vaccinia vector vaccine].
    Hashizume S; Morita M; Takahashi F
    Nihon Rinsho; 1987 Oct; 45(10):2333-41. PubMed ID: 3482288
    [No Abstract]   [Full Text] [Related]  

  • 7. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. m. Infection defense antigens of hepatitis A virus and genetic code].
    Ashida M; Hamada C
    Nihon Rinsho; 1987 Oct; 45(10):2298-305. PubMed ID: 2452261
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular approaches to vaccines.
    Bachrach HL
    Basic Life Sci; 1986; 37():217-42. PubMed ID: 3085649
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemically defined antiviral vaccines.
    Arnon R
    Annu Rev Microbiol; 1980; 34():593-618. PubMed ID: 6159823
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome structure and replication of oncornaviruses.
    Kisselev LL; Frolova LY
    Folia Biol (Praha); 1979; 25(1):1-35. PubMed ID: 371992
    [No Abstract]   [Full Text] [Related]  

  • 11. Localization of the coding region for a 35000 Dalton polypeptide on the genome of herpes simplex virus type 2.
    Suh M; Chauvin C; Filion M; Shore GC; Frost E
    J Gen Virol; 1983 Sep; 64 (Pt 9)():2079-85. PubMed ID: 6310044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the epitope-specific T cell response to virus infections.
    Soethout EC; Meiring HD; de Jong AP; van Els CA
    Vaccine; 2007 Apr; 25(16):3200-3. PubMed ID: 17276553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of genetic engineering methods to create viral vaccines].
    Tatarov G
    Vet Med Nauki; 1987; 24(1):88-92. PubMed ID: 3303657
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
    Tikhonenko TI
    Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of viral epitopes expressed on genetically and enzymatically engineered immunoglobulins.
    Bona CA; Bot A; Brumeanu TD
    Chem Immunol; 1997; 65():179-206. PubMed ID: 9018878
    [No Abstract]   [Full Text] [Related]  

  • 16. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.
    Burrows SR; Gardner J; Khanna R; Steward T; Moss DJ; Rodda S; Suhrbier A
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2489-93. PubMed ID: 7521394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV immunization. Fresh pathways to follow.
    Bolognesi DP
    Nature; 1990 Apr; 344(6269):818-9. PubMed ID: 1691822
    [No Abstract]   [Full Text] [Related]  

  • 18. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. n. Gene structure of HTLV and infection defense antigens].
    Maruyama T; Sugimoto M
    Nihon Rinsho; 1987 Oct; 45(10):2306-11. PubMed ID: 2896258
    [No Abstract]   [Full Text] [Related]  

  • 19. Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects.
    Zhang E; Kosinska AD; Ma Z; Dietze KK; Xu Y; Meng Z; Zhang X; Wang J; Wang B; Dittmer U; Roggendorf M; Yang D; Lu M
    Virology; 2015 Jan; 475():56-65. PubMed ID: 25462346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral vaccines: the use of currently available products and future developments.
    Norrby E
    Arch Virol; 1983; 76(3):163-77. PubMed ID: 6870545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.